Top View
- Edoxaban Clinical Guide
- Ethylenediaminetetraacetic Acid (EDTA) – Dependent Pathology Section Pseudothrombocytopenia: a Case Report
- LIXIANA® (Edoxaban)
- SAVAYSA (Edoxaban) Tablets for Oral Use Ml/Min (2.1) Initial U.S
- Heparin Sodium Injection BP
- Recommended Doses of Anticoagulant/Antithrombotic Therapies for Patients with Atrial Fibrillation
- Bericht ATC-Code B01: Antithrombotische Mittel
- Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients with Unstable Angina a Meta-Analysis Allison Oler, MD; Mary A
- Oral Anticoagulant (Warfarin) Guidelines
- Unfractionated Heparin, LMWH & Fondaparinux
- HEPARIN SODIUM, for Intravenous Use USP Units Per 500 Ml) in Single-Dose Freeflex® Bag Initial U.S
- Introduction to Drug Utilization Research 2003 Introduction to Drug Utilization Research
- Anti-Platelet and Anti-Coagulant Prescriptions and Breast Cancer Recurrence: a Danish Nationwide Prospective Cohort Study
- CLEXANE NZ Data Sheet
- Oral Anticoagulants
- Some Side Effects of Heparin, Heparinoids, and Their Antagonists
- Transition of Anticoagulants 2014
- Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)
- Applying Evidence-Based Guidelines for Anticoagulant Therapy in The
- Collection Tube Guide for the Full Array of BD Vacutainer® Blood Collection Tubes, Visit
- Adult Heparin Infusion Protocol This Protocol Reflects Current Evidence-Based Clinical Practice
- Direct Thrombin Inhibitors
- Low Molecular Weight Heparin and Unfractionated Heparin for the Prevention of Venous Thromboembolic Events in Medical And
- Switching to and from Various Anticoagulants
- Heparinoids: Structure, Biological Activities and Therapeutic Applications
- A Rationale for the Possible Role of Heparin/Heparinoid Antithrombotics in the Management of COVID-19 Infection
- Guidelines for ATC Classification and DDD Assignment 2021
- Anticoagulants: the Quick Guide to Use and Reversal
- Standard Heparin, Low Molecular Weight Heparin, Low Molecular Weight Heparinoid, and Recombinant Hirudin Differ in Their Ability
- Predicting Anatomic Therapeutic Chemical Classification Codes Using Tiered Learning Thomas Olson1† and Rahul Singh1,2*†
- (UFH) SC LMWH Or Fondaparinux Rivaroxaban
- ELIQUIS Safely and Effectively
- Venous Thromboembolism Prophylaxis Adult Inpatient
- Heparin Sodium Injection
- Comparison of Hematologic Values in Blood Samples with Lithium
- Enoxaparin Sodium Injection Full Prescribing Information
- The Use of Sodium Enoxaparin in the Treatment of Tinnitus
- Guidelines for ATC Classification and DDD Assignment 2013
- VTE Prophylaxis Guidelines
- Heparin (Mucous) Injection BP 1,000 and 5,000 Units/Ml
- COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/PBIRG ANATOMICAL CLASSIFICATION
- Guidelines for the Management of Anticoagulant Agents
- Direct Thrombin Inhibitors
- Use of Anticoagulants in Diagnostic Laboratory Investigations
- Guideline for the Prevention of Venous Thromboembolism (VTE) in Adult Hospitalised Patients December 2018
- Guidelines- Anticoagulation: Heparin & Warfarin
- Patient Medication Guide BIO-ENOX (Low Molecular Weight Heparin
- Periprocedural Antithrombotic Management for Lumbar Puncture
- BD Vacutainer®
- Lovenox Safely and • Effectively
- Peri-Procedure Management of Anticoagulants
- Fibrinolysis Plasminogen Activator Expression and the Mast Cell As
- Bridging Warfarin with Parenteral Anticoagulants
- Direct Oral Anticoagulants (Doacs)
- Bridging Anticoagulation Primum Non Nocere
- Transition of Anticoagulants 2019
- Enoxaparin: Overview for Providers